Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Smith & Nephew plc (SNN) vs Vanguard International High Dividend Yield ETF (VYMI) Price & Performance

Smith & Nephew plcTrade
Vanguard International High Dividend Yield ETFTrade

Price performance (Past 24H)

Key statistics

Smith & Nephew plc vs Vanguard International High Dividend Yield ETF — how do they compare? Smith & Nephew plc trades at $30.45 (market cap $12.64B), while Vanguard International High Dividend Yield ETF trades at $101.33. The key difference: Smith & Nephew plc pays a 2.57% dividend while Vanguard International High Dividend Yield ETF pays none, and Vanguard International High Dividend Yield ETF is trading nearer its 52-week high, Smith & Nephew plc nearer its low. Which is the better fit depends on your goals.

SNNVYMI
Market Cap
$12.64B
Sector
HealthBroad Market / Factor
52-Week High
$38.70$101.60
52-Week Low
$28.73$79.95
Enterprise Value
$15.41B
Dividend Yield
2.57%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Smith & Nephew plc

SNN trades at $30.21, down 1.24% today, with a bearish technical signal and mixed earnings history. Revenue grew to $5.81B in 2024 with net income of $412M, while valuation ratios like P/E of 21.25 and P/S of 2.15 suggest moderate pricing. Recent news highlights product launches in robotics and wound care, supporting growth initiatives.

Outlook is cautiously optimistic with strong cash flow and analyst buy ratings at 27%, but risks include earnings misses and rising debt. The stock offers potential from operational improvements, though investor sentiment remains divided amid competitive pressures.

Vanguard International High Dividend Yield ETF

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

About Smith & Nephew plc

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Read more on SNN

About Vanguard International High Dividend Yield ETF

VYMI is an index-based ETF that provides exposure to non-U.S. companies across developed and emerging markets that are characterized by high dividend yields. It tracks the FTSE All-World ex US High Dividend Yield Index, offering a diversified, low-cost way to capture international income while serving as a tactical hedge against U.S. market concentration.

Read more on VYMI